Cargando…
Proteotoxicity and Neurodegenerative Diseases
Neurodegenerative diseases are a major burden for our society, affecting millions of people worldwide. A main goal of past and current research is to enhance our understanding of the mechanisms underlying proteotoxicity, a common theme among these incurable and debilitating conditions. Cell proteome...
Autores principales: | Ruz, Clara, Alcantud, Jose Luis, Vives Montero, Francisco, Duran, Raquel, Bandres-Ciga, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460676/ https://www.ncbi.nlm.nih.gov/pubmed/32781742 http://dx.doi.org/10.3390/ijms21165646 |
Ejemplares similares
-
Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome
por: Ruz, Clara, et al.
Publicado: (2022) -
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
por: McAlary, Luke, et al.
Publicado: (2019) -
Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead
por: Lake, Julie, et al.
Publicado: (2021) -
Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
por: Alvarez Jerez, Pilar, et al.
Publicado: (2023) -
Seventy-Two-Hour LRRK2 Kinase Activity Inhibition Increases Lysosomal GBA Expression in H4, a Human Neuroglioma Cell Line
por: Ruz, Clara, et al.
Publicado: (2022)